연구
-
-
연구
-
연구업적
연구업적
최근 5년 연구업적 현황
| 연도 | 2023년 | 2022년 | 2021년 | 2020년 | 2019년 | |
|---|---|---|---|---|---|---|
| SCI 논문 발표편수 |
책임 | 173편 | 163편 | 184편 | 135편 | 144편 |
| 공동 | 120편 | 115편 | 136편 | 168편 | 167편 | |
| 합계 | 293편 | 278편 | 320편 | 303편 | 311편 | |
2971. Efficacy of Prophylactic Cranial Irradiation According to the Risk of Extracranial Recurrence in Limited-Stage Small Cell Lung Cancer
Lee TH, Chung JH, Wu HG, Kim S, Lee JH, Keam B, Kim JS, Kim KH, Kim BH, Kim HJ
Cancer Res Treat. 2023 Jul;55(3):875-884
Link
2970. Effect of Lactobacillus Rhamnosus GG for Regulation of Inflammatory Response in Radiation-Induced Enteritis
Lee SU, Jang BS, Na YR, Lee SH, Han S, Chang JH, Kim HJ
Probiotics Antimicrob Proteins. 2023 Apr 18
Link
2969. Regional lymph node recurrence after stereotactic body radiation therapy for lung cancer: Patterns of recurrence, treatment approaches, and clinical outcomes (KROG 21-09)
Lee TH, Shin H, Ahn YC, Kang MK, Song C, Kim WC, Moon SH, Kim JH, Cho J, Park HJ, Lee HK, Kim BH, Kim HJ
Radiother Oncol. 2023 Jun;183:109572
Link
2968. No survival benefit with early incorporation of thoracic radiotherapy using daily fractionation in patients with limited-stage small cell lung cancer undergoing chemoradiotherapy in the modern era: A systematic review and meta-analysis
Kim BH, Song C, Kim HJ
Radiother Oncol. 2023 Jul;184:109696
Link
2967. Cancer signature ensemble integrating cfDNA methylation, copy number, and fragmentation facilitates multi-cancer early detection.
Kim SY, Jeong S, Lee W, Jeon Y, Kim YJ, Park S, Lee D, Go D, Song SH, Lee S, Woo HG, Yoon JK, Park YS, Kim YT, Lee SH, Kim KH, Lim Y, Kim JS, Kim HP, Bang D, Kim TY.
Exp Mol Med.
2023 Nov;55(11):2445-2460.
Link
2966. Epigenetic insights into colorectal cancer: comprehensive genome-wide DNA methylation profiling of 294 patients in Korea.
Joe S, Kim J, Lee JY, Jeon J, Byeon I, Han SW, Ryoo SB, Park KJ, Song SH, Cho S, Shim H, Bao Khanh Chu H, Kang J, Lee HS, Kim D, Kim YJ, Kim TY, Kim SY.
BMB Rep.
2023 Oct;56(10):563-568.
Link
2965. Efficacy of Olaparib in Treatment-Refractory, Metastatic Breast Cancer with Uncommon Somatic BRCA Mutations Detected in Circulating Tumor DNA.
Yoon JK, Ahn J, Kim S, Kim HP, Kang JK, Bang D, Lim Y, Kim TY.
Cancer Res Treat.
2023 Jul;55(3):1048-1052
Link
2964. Spatial and clonality-resolved 3D cancer genome alterations reveal enhancer-hijacking as a potential prognostic marker for colorectal cancer.
Kim K, Kim M, Lee AJ, Song SH, Kang JK, Eom J, Kang GH, Bae JM, Min S, Kim Y, Lim Y, Kim HS, Kim YJ, Kim TY, Jung I
Cell Rep.
2023 Jul 25;42(7):112778.
Link
2963. Treated chronic hepatitis B is a good prognostic factor of diffuse large B-cell lymphoma
Jeayeon Park 1, Sung Won Chung 1, Yun Bin Lee 1, Hyunjae Shin 1, Moon Haeng Hur 1, Heejin Cho 1, Min Kyung Park 1, Jeonghwan Youk 2, Ji Yun Lee 3, Jeong-Ok Lee 3, Su Jong Yu 1, Yoon Jun Kim 1, Jung-Hwan Yoon 1, Tae Min Kim 2, Jeong-Hoon Lee 1
Clin Mol Hepatol
. 2023 Jul;29(3):794-809.
Link
2962. Impact of T-cell Engagers on COVID-19-related Mortality in B-cell Lymphoma Patients Receiving B-cell Depleting Therapy
Chan Mi Lee 1, Pyoeng Gyun Choe 1, Chang Kyung Kang 1, Hyeon Jae Jo 1, Nam Joong Kim 1, Sung-Soo Yoon 1, Tae Min Kim 1 2, Wan Beom Park 1, Myoung-Don Oh 1
Cancer Res Treat
. 2023 Jul 6.
Link